Showing results (71-80 of 91) with videos related to
Sort By:
Pageof 10
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 12, 2023
The KAT6B::KANSL1 Fusion Defines a New Uterine Sarcoma With Hybrid Endometrial Stromal Tumor and Smooth Muscle Tumor FeaturesAlexis Trecourt, Rihab Azmani, Isabelle Hostein, et al.Histopathology|November 21, 2023
Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfallsMadalena Souto Moura, João Costa, Valérie Velasco, et al.EMBO Reports|February 6, 2023
The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potentialKenji F Shoji, Elsa Bayet, Sabrina Leverrier-Penna, et al.The American Journal of Surgical Pathology|July 17, 2024
Comprehensive Molecular Characterization of a Large Series of Calcified Chondroid Mesenchymal Neoplasms Widening Their Morphologic SpectrumClément Benard, François Le Loarer, Anne Gomez-Mascard, et al.Histopathology|November 22, 2022
NTRK-rearranged spindle cell neoplasms are ubiquitous tumours of myofibroblastic lineage with a distinct methylation classArnault Tauziède-Espariat, Mathilde Duchesne, Jessica Baud, et al.The American Journal of Surgical Pathology|November 20, 2018
SMARCA4-deficient Thoracic Sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential DiagnosesRaul Perret, Lara Chalabreysse, Sarah Watson, et al.Thyroid : Official Journal of the American Thyroid Association|March 30, 2017
Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 CasesBenjamin Bonhomme, Yann Godbert, Gaelle Perot, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 17, 2020
Correction: NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic markerRaul Perret, Julien Escuriol, Valérie Velasco, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 25, 2020
NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic markerRaul Perret, Julien Escuriol, Valérie Velasco, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Trabectedin plus Durvalumab in Patients with Advanced Pretreated Soft Tissue Sarcoma and Ovarian Carcinoma (TRAMUNE): An Open-Label, Multicenter Phase Ib StudyMaud Toulmonde, Mehdi Brahmi, Antoine Giraud, et al.Pageof 10